TareBio logo

TareBio

Vaccines for any cancer or infection in weeks

Summer 2026Healthcare / Healthcare -> Drug Discovery and DeliverySan Francisco, CA, USA1 employees
Vaccines
Synthetic Biology
Biotechnology

About

Our platform develops personalized or population-level vaccines for any disease in weeks by changing only one input: the immune imprint. Instead of trying to predict which antigens might work, we read out immune cells already fighting the disease in the body and reverse-engineer antigens that activate them. We've already run our platform end-to-end and created a vaccine that cured cancer in mice.

Build your own investing agent

GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.

Join the GPAgent waitlist

Founders (1)

Eta Atolia
Founder

Details

Status
Active
Stage
Early
Team Size
1
Regions
United States of America, America / Canada